Literature DB >> 7437011

An enumerative assay of purine analogue resistant lymphocytes in women heterozygous for the Lesch-Nyhan Mutation.

G H Strauss, E F Allen, R J Albertini.   

Abstract

In females heterozygous for the Lesch-Nyhan (LN) mutation, there is mosaicism of peripheral blood lymphocytes (PBLs) with regard to sensitivity to 6-thioguanine (TG) inhibition of tritiated thymidine ([3H]Tdr) incorporation following phytohemagglutinin (PHA) stimulation. That there are two populations of PBLs, normal and mutant (LN-like), has been demonstrated by an autoradiographic enumerative assay. A single three-generation family containing six potentially heterozygous females was studied. Five of the six were mosaics with frequencies of TG-resistant (TGr) PBLs rangling from 1.4 x 10(-3) to 4.2 x 10(-3) when tested at 2 x 10(-4) M TG. The median frequency of TGr PBLs in 63 healthy non-LN individuals between the ages of 11 and 75 years was found to be 1.1 x 10(-4) (mean 1.3 x 10(-4)) (10th and 90th percentiles--6.1 x 10(-5) and 2.1 x 10(-4)) and was not age related. The sixth potentially heterozygous female in the current family had a TGr PBL frequency of 1.9 x 10(-4). In the five females with elevated TGr PBL frequencies, TGr skin fibroblasts with frequencies ranging from 26% to 100% of the sample tested were found; in the female with the normal TGr PBL frequency, no TGr skin fibroblasts were found. The former group was considered to be LN heterozygous. Four of the five had been previously diagnosed as such. The latter individual is considered to be genotypically normal. Females who are heterozygotes for the LN mutation have two populations of PBLs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437011     DOI: 10.1007/bf00484400

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  35 in total

1.  DEMONSTRATION OF TWO POPULATIONS OF CELLS IN THE HUMAN FEMALE HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE VARIANTS.

Authors:  R G DAVIDSON; H M NITOWSKY; B CHILDS
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

2.  Lesch-Nyhan syndrome: absence of the mutant enzyme in erythrocytes of a heterozygote for both normal and mutant hypoxanthine-guanine phosphoribosyl transferase.

Authors:  J A McDonald; W N Kelley
Journal:  Biochem Genet       Date:  1972-02       Impact factor: 1.890

3.  Somatic cell mutation. Detection and quantification of x-ray-induced mutation in cultured, diploid human fibroblasts.

Authors:  R J Albertini; R DeMars
Journal:  Mutat Res       Date:  1973-05       Impact factor: 2.433

4.  Variability of the time at which PHA-stimulated lymphocytes initiate DNA synthesis.

Authors:  L Sörén
Journal:  Exp Cell Res       Date:  1973-03-30       Impact factor: 3.905

5.  Isoenzymes of hypoxanthine-guanine-phosphoribosyl transferase in a family with partial deficiency of the enzyme.

Authors:  B Bakay; W L Nyhan; N Fawcett; M D Kogut
Journal:  Biochem Genet       Date:  1972-08       Impact factor: 1.890

6.  Purine base incorporation into erythrocyte nucleotides in hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  O Sperling; G Eilam; R Schmidt; G Mundel; A De Vries
Journal:  Biochem Med       Date:  1971-04

7.  Lymphocyte transformation in vitro. I. Tissue culture conditions and quantitative measurements.

Authors:  P T Schellekens; V P Eijsvoogel
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

8.  An hypothesis on the mechanism of action of 6-thioguanine.

Authors:  R P Miech; R E Parks; J H Anderson; A C Sartorelli
Journal:  Biochem Pharmacol       Date:  1967-11       Impact factor: 5.858

9.  Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts.

Authors:  W Y Fujimoto; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

10.  6-Thioguanine resistant peripheral blood lymphocytes in humans following psoralen, long-wave ultraviolet light (PUVA) therapy.

Authors:  G H Strauss; R J Albertini; P A Krusinski; R D Baughman
Journal:  J Invest Dermatol       Date:  1979-09       Impact factor: 8.551

View more
  4 in total

1.  Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures.

Authors:  T R Skopek; L Recio; D Simpson; L Dallaire; S B Melancon; H Ogier; J P O'Neill; M T Falta; J A Nicklas; R J Albertini
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

2.  Skewed X inactivation in Lesch-Nyhan disease carrier females.

Authors:  Rosa J Torres; Juan G Puig
Journal:  J Hum Genet       Date:  2017-09-14       Impact factor: 3.172

3.  Detection of the carrier state for an X-linked disorder, the Lesch-Nyhan syndrome, by the use of lymphocyte cloning.

Authors:  J L Dempsey; A A Morley; R S Seshadri; B T Emmerson; R Gordon; C I Bhagat
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients.

Authors:  K Fukuchi; K Tanaka; Y Kumahara; K Marumo; M B Pride; G M Martin; R J Monnat
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.